An up-to-date timeline of U.S. Food and Drug Administration (FDA) approvals that could potentially impact workers' compensation. These include new drug and indication approvals, new dosages or formulations of existing products, and generics introduced to the market. Click through the interactive timeline below, or select the comprehensive list view.
← Back to Medmonitor

MedAlert Tag: Seizure

Sagent Pharmaceuticals Recalls Four Lots of Levetiracetam

November 19, 2021

Sagent Pharmaceuticals issued a recall for four lots of Levetiracetam Injection, USP due to a lack of sterility assurance. Levetiracetam is used for the treatment of certain types of seizures. Intravenous administration of a product intended to be sterile that is not sterile could result in serious systemic infections which may be life threatening. Lot numbers recalled include BOG85VB, BOK88VA, BOK89VA, and B1G194A.

Read More